Allergen has acquired Chase Pharmaceuticals Corporation from New Rhein Healthcare Investors for a purchase consideration of $125m.

Pursuant to the agreement, Chase Pharma will be merged with a subsidiary of Allergan, and Allergan will be responsible to pay additional potential regulatory and sales milestone-based payments to Chase Pharma.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The acquisition will allow the acquirer to further expand its CNS research and development (R&D) pipeline.

"The acquisition will allow the acquirer to further expand its CNS research and development (R&D) pipeline."

Primex Pharmaceuticals has acquired Giovanni Ogna& Figli with the aim of expanding its product portfolio of dental surgery products.

Pursuant to the agreement, Primex will merge all the former OGNA companies into the original company, Giovanni Ogna et Figli.

Chiesi Farmaceutici plans to acquire Atopix Therapeutics by purchasing all its outstanding shares for a purchase consideration of $79.4m.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The acquisition will enable Chiesi Framaceutici to expand its product portfolio for respiratory and eosinophilic airways diseases.

Clinical Trials Arena Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Clinical Trials Arena Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving clinical trials industry advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now